|More News >>|
Sexually transmitted diseases (STDs) can be a taboo area of study, even in the world of science. Indiana University biologist David Nelson says, as a result, there are significant holes in what scientists know about them. Fueled by a recent $2.3 million grant, a team of IU researchers will strive to fully understand the biology of chlamydia, with the ultimate goal of creating a vaccine for the disease—the most commonly reported bacterial infectious disease in the U.S.
Research at the undergraduate level is key to generating the highly skilled workforce that will foster the growth of Indiana's technology-driven economy.
Inside INdiana Business, BioCrossroads and Indiana University have launched a new partnership to communicate the growth, success and excitement surrounding Indiana's life sciences industry. We share a belief that this innovative field plays a vital role in the development of the entrepreneurs, innovations and businesses that will allow Indiana to compete in a global economy. Life Sciences INdiana is published by the special projects unit of Grow INdiana Media Ventures LLC, the parent company of the Inside INdiana Business brand of business news products.
To submit a story or ask a question, please contact
The video and audio excerpts are licensed for private, non-commercial use only. Any other use is strictly prohibited without the expressed, written permission of Grow Indiana Media Ventures, LLC. Duplication in whole or part of the video or audio contained within is strictly prohibited. All other rights reserved.